Krishna Gunturu
Hematology & Oncology · Plainville, CTNPI 1699881037
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $31,008 of the $36,779 with a category attached, or 84.3%. It is spread thinly across 14 manufacturers, the largest accounting for just 23.9%. Among hematology & oncology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 57 payments — averaging $645.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$9K
- AstraZeneca$7K
- Amgen$7K
- Eisai Inc.$6K
- Lilly USA, LLC$5K
- G1 Therapeutics, Inc.$2K
- plus $2K from 8 others
Across 175 payments — averaging $4554.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Exelixis Inc.$652K
- F. Hoffmann-la Roche AG$125K
- Genentech, Inc.$9K
- Merck$5K
- Bayer$3K
- Amgen$3K
- plus $640 from 1 others
What the payments were for
- Consulting fees$31,00884%
- Speaking & faculty fees$1,5004%
- Travel & lodging$2,9538%
- Food & beverage$1,1203%
- Education$1991%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 12 | $8,795 |
| AstraZeneca | 4 | $7,266 |
| Amgen | 5 | $6,860 |
| Eisai Inc. | 15 | $6,055 |
| Lilly USA, LLC | 9 | $4,553 |
| G1 Therapeutics, Inc. | 1 | $1,500 |
| Daiichi Sankyo Inc. | 1 | $1,350 |
| Seagen Inc. | 2 | $130 |
| Springworks Therapeutics, Inc. | 1 | $82 |
| Genentech USA, Inc. | 1 | $57 |
| Pfizer | 3 | $50 |
| Gilead | 1 | $33 |
| Tempus AI, Inc | 1 | $24 |
| Johnson & Johnson | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$36,779 in reported general payments places this provider in the 90th percentile of 163 hematology & oncology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 13 | $235 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Plainville
- Daniel MorgansternPlainville$10K
- Joseph SinningPlainville$6K
- Amer ZeidanNew Haven$807K
- Biree AndemariamFarmington$646K
- Paul WeinsteinStamford$288K
- Walid ShaibNew Haven$217K
- Madhavi GorusuHartford$207K
- Dinesh KapurNorwich$201K
- Scott HuntingtonNew Haven$163K
- Nataliya UbohaNew Haven$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.